Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Morgan

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 2005
Candida kefyr as an emerging pathogen causing nosocomial bloodstream infections in neutropenic leukemia patientsChristoph W M Reuter, Michael A Morgan, Franz-Christoph Bange, et al.
Biomedicines|October 23, 2021
NK Cell-Mediated Eradication of Ovarian Cancer Cells with a Novel Chimeric Antigen Receptor Directed against CD44Rüdiger Klapdor, Shuo Wang, Michael A Morgan, et al.
Journal of Molecular Medicine (Berlin, Germany)|December 6, 2023
Correction to: Efficient generation of gene-modified human natural killer cells via alpharetroviral vectorsJulia D Suerth, Michael A Morgan, Stephan Kloess, et al.
Journal of Molecular Medicine (Berlin, Germany)|August 25, 2015
Efficient generation of gene-modified human natural killer cells via alpharetroviral vectorsJulia D Suerth, Michael A Morgan, Stephan Kloess, et al.
Molecular & Cellular Proteomics : MCP|January 28, 2010
A tagging-via-substrate approach to detect the farnesylated proteome using two-dimensional electrophoresis coupled with Western blottingFredrick O Onono, Michael A Morgan, H Peter Spielmann, et al.
Scientific Reports|March 6, 2021
Conditionally immortalised leukaemia initiating cells co-expressing Hoxa9/Meis1 demonstrate microenvironmental adaptation properties ex vivo while maintaining myelomonocytic memoryMaike Stahlhut, Teng Cheong Ha, Ekaterina Takmakova, et al.
Journal of Microbiological Methods|February 10, 2007
Staining of Chlamydia trachomatis elementary bodies: a suitable method for identifying infected human monocytes by flow cytometryKaren Schnitger, Florence Njau, Ulrike Wittkop, et al.
Journal of Molecular Medicine (Berlin, Germany)|September 15, 2011
Modulation of anthracycline-induced cytotoxicity by targeting the prenylated proteome in myeloid leukemia cellsMichael A Morgan, Fredrick O Onono, H Peter Spielmann, et al.
Viruses|August 10, 2021
Improved Activity against Acute Myeloid Leukemia with Chimeric Antigen Receptor (CAR)-NK-92 Cells Designed to Target CD123Michael A Morgan, Arnold Kloos, Daniela Lenz, et al.
Frontiers in Immunology|November 19, 2015
Cetuximab Reconstitutes Pro-Inflammatory Cytokine Secretions and Tumor-Infiltrating Capabilities of sMICA-Inhibited NK Cells in HNSCC Tumor SpheroidsStephan Klöss, Nicole Chambron, Tanja Gardlowski, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 2005
Candida kefyr as an emerging pathogen causing nosocomial bloodstream infections in neutropenic leukemia patientsChristoph W M Reuter, Michael A Morgan, Franz-Christoph Bange, et al.
Biomedicines|October 23, 2021
NK Cell-Mediated Eradication of Ovarian Cancer Cells with a Novel Chimeric Antigen Receptor Directed against CD44Rüdiger Klapdor, Shuo Wang, Michael A Morgan, et al.
Journal of Molecular Medicine (Berlin, Germany)|December 6, 2023
Correction to: Efficient generation of gene-modified human natural killer cells via alpharetroviral vectorsJulia D Suerth, Michael A Morgan, Stephan Kloess, et al.
Journal of Molecular Medicine (Berlin, Germany)|August 25, 2015
Efficient generation of gene-modified human natural killer cells via alpharetroviral vectorsJulia D Suerth, Michael A Morgan, Stephan Kloess, et al.
Molecular & Cellular Proteomics : MCP|January 28, 2010
A tagging-via-substrate approach to detect the farnesylated proteome using two-dimensional electrophoresis coupled with Western blottingFredrick O Onono, Michael A Morgan, H Peter Spielmann, et al.
Scientific Reports|March 6, 2021
Conditionally immortalised leukaemia initiating cells co-expressing Hoxa9/Meis1 demonstrate microenvironmental adaptation properties ex vivo while maintaining myelomonocytic memoryMaike Stahlhut, Teng Cheong Ha, Ekaterina Takmakova, et al.
Journal of Microbiological Methods|February 10, 2007
Staining of Chlamydia trachomatis elementary bodies: a suitable method for identifying infected human monocytes by flow cytometryKaren Schnitger, Florence Njau, Ulrike Wittkop, et al.
Journal of Molecular Medicine (Berlin, Germany)|September 15, 2011
Modulation of anthracycline-induced cytotoxicity by targeting the prenylated proteome in myeloid leukemia cellsMichael A Morgan, Fredrick O Onono, H Peter Spielmann, et al.
Viruses|August 10, 2021
Improved Activity against Acute Myeloid Leukemia with Chimeric Antigen Receptor (CAR)-NK-92 Cells Designed to Target CD123Michael A Morgan, Arnold Kloos, Daniela Lenz, et al.
Frontiers in Immunology|November 19, 2015
Cetuximab Reconstitutes Pro-Inflammatory Cytokine Secretions and Tumor-Infiltrating Capabilities of sMICA-Inhibited NK Cells in HNSCC Tumor SpheroidsStephan Klöss, Nicole Chambron, Tanja Gardlowski, et al.
Pageof 4